[fcb5af]: / literature / by_gene_clean / FOXO1.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 33327711 10.3324/haematol.2020.263194 2022 Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma. FOXO1
2 34265801 10.1097/PAS.0000000000001780 2022 Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation. FOXO1
3 34617271 10.1111/bjh.17874 2022 Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. FOXO1
4 34894199 10.1002/mnfr.202100564 2022 Green Alga Enteromorpha prolifera Oligosaccharide Ameliorates Ageing and Hyperglycemia through Gut-Brain Axis in Age-Matched Diabetic Mice. FOXO1
5 35045798 10.1080/10428194.2021.2024821 2022 High grade B-cell lymphoma with <i>MYC</i>, <i>BCL2</i> and/or <i>BCL6</i> rearrangements: unraveling the genetic landscape of a rare aggressive subtype of non-Hodgkin lymphoma. FOXO1
6 35079069 10.1038/s41598-022-05334-4 2022 FOXO1 forkhead domain mutants in B-cell lymphoma lack transcriptional activity. FOXO1
7 35176466 10.1016/j.jep.2022.115095 2022 Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and invasion by inhibiting G9a in non-small-cell lung cancer A549 cells. FOXO1
8 35511481 10.1080/09553002.2022.2074164 2022 <i>BAG1, MGMT, FOXO1</i>, and <i>DNAJA1</i> as potential drug targets for radiosensitizing cancer cell lines. FOXO1
9 35578798 10.1002/jcp.30777 2022 Neddylation inactivation affects cell cycle and apoptosis in sheep follicular granulosa cells. FOXO1
10 35774848 10.1155/2022/3276925 2022 Identification of CXCR4 Upregulation in Diffuse Large B-Cell Lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics. FOXO1
11 35895105 10.1021/acs.biochem.2c00224 2022 Oncogenic Mutations in the DNA-Binding Domain of FOXO1 that Disrupt Folding: Quantitative Insights from Experiments and Molecular Simulations. FOXO1
12 35910796 10.7150/thno.72786 2022 Inhibition of acylglycerol kinase sensitizes DLBCL to venetoclax via upregulation of FOXO1-mediated BCL-2 expression. FOXO1
13 33152216 10.5713/ajas.20.0444 2021 Role of stearyl-coenzyme A desaturase 1 in mediating the effects of palmitic acid on endoplasmic reticulum stress, inflammation, and apoptosis in goose primary hepatocytes. FOXO1
14 33508992 10.1080/10428194.2021.1876857 2021 Tamoxifen enhances romidepsin-induced apoptosis in T-cell malignant cells via activation of FOXO1 signaling pathway. FOXO1
15 33821300 10.1007/s00540-021-02909-9 2021 Dexmedetomidine ameliorates lipopolysaccharide-induced acute lung injury by inhibiting the PI3K/Akt/FoxO1 signaling pathway. FOXO1
16 34140493 10.1038/s41467-021-24037-4 2021 Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified. FOXO1
17 34374220 10.1002/cjp2.223 2021 c-MYC and p53 expression highlight starry-sky pattern as a favourable prognostic feature in R-CHOP-treated diffuse large B-cell lymphoma. FOXO1
18 34380064 10.1016/j.immuni.2021.07.009 2021 Mutations in the transcription factor FOXO1 mimic positive selection signals to promote germinal center B cell expansion and lymphomagenesis. FOXO1
19 34506757 10.1016/j.abb.2021.109026 2021 SMC4 knockdown inhibits malignant biological behaviors of endometrial cancer cells by regulation of FoxO1 activity. FOXO1
20 34599153 10.1038/s41419-021-04187-5 2021 Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma. FOXO1
21 34679437 10.3390/diagnostics11101739 2021 Dysregulation of miRNAs in DLBCL: Causative Factor for Pathogenesis, Diagnosis and Prognosis. FOXO1
22 34948236 10.3390/ijms222413441 2021 Akt Signaling Pathway Is Activated in the Minor Salivary Glands of Patients with Primary Sjögren's Syndrome. FOXO1
23 31423576 10.1111/bjh.16159 2020 M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy. FOXO1
24 31872845 10.1039/c9fo02491c 2020 Calcium relieves fluoride-induced bone damage through the PI3K/AKT pathway. FOXO1
25 32342940 NA 2020 Metastatic alveolar rhabdomyosarcoma on the fine-needle aspiration cytology of cervical lymph node in an elderly patient, with FISH confirmation: A case report. FOXO1
26 32373978 10.26355/eurrev_202004_21022 2020 MiRNA-584 suppresses the progression of NK/T-cell lymphoma by targeting FOXO1. FOXO1
27 32905193 10.1093/toxres/tfaa059 2020 Alogliptin: a novel approach against cyclophosphamide-induced hepatic injury via modulating SIRT1/FoxO1 pathway. FOXO1
28 33038355 10.1016/j.neuro.2020.10.001 2020 Quercetin provides protection against the peripheral nerve damage caused by vincristine in rats by suppressing caspase 3, NF-κB, ATF-6 pathways and activating Nrf2, Akt pathways. FOXO1
29 33045225 10.1016/j.humpath.2020.09.014 2020 The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma. FOXO1
30 33207194 10.1016/j.celrep.2020.108403 2020 Cyclin D3 Governs Clonal Expansion of Dark Zone Germinal Center B Cells. FOXO1
31 33252851 10.1002/ctm2.221 2020 Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma. FOXO1
32 30520026 10.1111/bjh.15702 2019 Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non-Hodgkin lymphoma. FOXO1
33 30628689 10.3892/mmr.2019.9827 2019 Low‑dose lipopolysaccharide inhibits neuronal apoptosis induced by cerebral ischemia/reperfusion injury via the PI3K/Akt/FoxO1 signaling pathway in rats. FOXO1
34 30998151 10.19746/j.cnki.issn.1009-2137.2019.02.021 2019 [Exploration of the Role of Tumor Suppressor Genes Foxo1 and PTEN in the Tumorigenesis of Mouse Natural Killer-Cell Lymphoma]. FOXO1
35 31203134 10.1016/j.biopha.2019.109092 2019 Estradiol promotes trophoblast viability and invasion by activating SGK1. FOXO1
36 31300419 10.1182/bloodadvances.2018029546 2019 Sporadic and endemic Burkitt lymphoma have frequent <i>FOXO1</i> mutations but distinct hotspots in the AKT recognition motif. FOXO1
37 31301310 10.1016/j.ejphar.2019.172531 2019 MicroRNA Let-7f-1-3p attenuates smoke-induced apoptosis in bronchial and alveolar epithelial cells in vitro by targeting FOXO1. FOXO1
38 31557894 10.3390/cancers11101427 2019 FOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt Lymphoma. FOXO1
39 31669559 10.1016/j.exphem.2019.10.004 2019 Depletion of the transcriptional coactivators CREB-binding protein or EP300 downregulates CD20 in diffuse large B-cell lymphoma cells and impairs the cytotoxic effects of anti-CD20 antibodies. FOXO1
40 31908892 10.20892/j.issn.2095-3941.2019.0115 2019 Inactivation of FOXO1 induces T follicular cell polarization and involves angioimmunoblastic T cell lymphoma. FOXO1
41 28774833 10.1016/j.semcancer.2017.07.008 2018 FOXO in B-cell lymphopoiesis and B cell neoplasia. FOXO1
42 29399633 10.1126/sciadv.aar5701 2018 Discrete roles and bifurcation of PTEN signaling and mTORC1-mediated anabolic metabolism underlie IL-7-driven B lymphopoiesis. FOXO1
43 29439954 10.1182/blood-2017-07-795278 2018 Fine-tuning of FOXO3A in cHL as a survival mechanism and a hallmark of abortive plasma cell differentiation. FOXO1
44 29545328 10.1182/blood-2017-11-817601 2018 Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma. FOXO1
45 29545835 10.3892/etm.2018.5853 2018 Expression and phosphorylation of FOXO1 influences cell proliferation and apoptosis in the gastrointestinal stromal tumor cell line GIST-T1. FOXO1
46 29721381 10.1080/2162402X.2017.1423183 2018 FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy. FOXO1
47 29937999 10.18632/oncotarget.25463 2018 Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma. FOXO1
48 30020823 10.1080/08880018.2018.1467986 2018 Epigenetic silencing of the tumor suppressor genes SPI1, PRDX2, KLF4, DLEC1, and DAPK1 in childhood and adolescent lymphomas. FOXO1
49 30259128 10.1007/s00702-018-1927-8 2018 Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy. FOXO1
50 30272279 10.3892/ijo.2018.4577 2018 Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression. FOXO1
51 30333121 10.1182/blood-2018-06-856203 2018 Nuclear FOXO1 promotes lymphomagenesis in germinal center B cells. FOXO1
52 30360879 10.1053/j.seminoncol.2018.07.005 2018 New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs. FOXO1
53 30462731 10.1371/journal.ppat.1007440 2018 Neddylation contributes to CD4+ T cell-mediated protective immunity against blood-stage Plasmodium infection. FOXO1
54 30524445 10.3389/fimmu.2018.02715 2018 The c-Myc/miR17-92/PTEN Axis Tunes PI3K Activity to Control Expression of Recombination Activating Genes in Early B Cell Development. FOXO1
55 28465297 10.1158/1541-7786.MCR-16-0305 2017 Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences. FOXO1
56 28550734 10.1016/j.intimp.2017.05.022 2017 Pterostilbene alleviates polymicrobial sepsis-induced liver injury: Possible role of SIRT1 signaling. FOXO1
57 28691928 10.1172/JCI92026 2017 Mutations in 5-methylcytosine oxidase TET2 and RhoA cooperatively disrupt T cell homeostasis. FOXO1
58 29113202 10.3892/ol.2017.6912 2017 EZH2 and histone deacetylase inhibitors induce apoptosis in triple negative breast cancer cells by differentially increasing H3 Lys<sup>27</sup> acetylation in the <i>BIM</i> gene promoter and enhancers. FOXO1
59 26033966 10.1136/gutjnl-2014-308270 2016 BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling. FOXO1
60 26585955 10.1182/blood-2015-06-654111 2016 FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas. FOXO1
61 26647218 10.1158/1078-0432.CCR-15-2123 2016 Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas. FOXO1
62 26686861 10.1007/s00018-015-2112-y 2016 FOXO transcription factors in cancer development and therapy. FOXO1
63 26764572 10.1038/cddis.2015.396 2016 FoxO3 suppresses Myc-driven lymphomagenesis. FOXO1
64 27132507 10.1038/onc.2016.126 2016 FOXO1 is a TXN- and p300-dependent sensor and effector of oxidative stress in diffuse large B-cell lymphomas characterized by increased oxidative metabolism. FOXO1
65 27166193 10.18632/oncotarget.9210 2016 Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis. FOXO1
66 27661108 10.18632/oncotarget.12132 2016 Acquired resistance to venetoclax (ABT-199) in t(14;18) positive lymphoma cells. FOXO1
67 27779675 10.3892/mmr.2016.5861 2016 Resveratrol alleviates sepsis‑induced myocardial injury in rats by suppressing neutrophil accumulation, the induction of TNF‑α and myocardial apoptosis via activation of Sirt1. FOXO1
68 27933060 10.3389/fimmu.2016.00520 2016 Regulators of Tfh Cell Differentiation. FOXO1
69 25691468 10.1101/gad.255331.114 2015 The E-Id protein axis modulates the activities of the PI3K-AKT-mTORC1-Hif1a and c-myc/p19Arf pathways to suppress innate variant TFH cell development, thymocyte expansion, and lymphomagenesis. FOXO1
70 25909227 10.18632/oncotarget.3729 2015 MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma. FOXO1
71 26256760 10.1016/S1470-2045(15)00169-2 2015 Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. FOXO1
72 26314988 10.1038/bcj.2015.69 2015 Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma. FOXO1
73 26398583 10.3892/or.2015.4287 2015 SIRT1 downregulation enhances chemosensitivity and survival of adult T-cell leukemia-lymphoma cells by reducing DNA double-strand repair. FOXO1
74 24427371 NA 2014 Nasopharyngeal alveolar rhabdomyosarcoma expressing CD56: a mimicker of extranodal natural killer/T-cell lymphoma. FOXO1
75 24614102 10.1172/JCI63139 2014 CDK4 deficiency promotes genomic instability and enhances Myc-driven lymphomagenesis. FOXO1
76 24977668 10.18632/oncotarget.2107 2014 FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma. FOXO1
77 25043849 10.1002/gcc.22204 2014 Deregulated FOX genes in Hodgkin lymphoma. FOXO1
78 25232062 10.1182/blood-2014-07-590570 2014 FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma. FOXO1
79 23174882 10.1038/leu.2012.280 2013 Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma. FOXO1
80 23460611 10.1182/blood-2013-01-479865 2013 Analysis of FOXO1 mutations in diffuse large B-cell lymphoma. FOXO1
81 23764004 10.1016/j.ccr.2013.05.002 2013 SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas. FOXO1
82 23772809 10.1111/joim.12099 2013 miR-223: infection, inflammation and cancer. FOXO1
83 22197543 10.1016/j.anndiagpath.2011.09.004 2012 Detection of PAX3/PAX7-FKHR fusion transcripts in rhabdomyosarcoma and other small round cell tumors by 1-step reverse transcriptase polymerase chain reaction: a novel tool for diagnosis and differentiation. FOXO1
84 22343918 10.1182/blood-2011-09-381905 2012 FOXO1 is a tumor suppressor in classical Hodgkin lymphoma. FOXO1
85 22570335 10.1210/me.2011-1276 2012 FOXO1 mediates the autocrine effect of endothelin-1 on endothelial cell survival. FOXO1
86 22966017 10.1158/1078-0432.CCR-12-0397 2012 Quantitative immunofluorescence reveals the signature of active B-cell receptor signaling in diffuse large B-cell lymphoma. FOXO1
87 21423089 NA 2011 CD150-mediated Akt signalling pathway in normal and malignant B cells. FOXO1
88 22110774 10.4161/derm.3.3.15331 2011 Isotretinoin and FoxO1: A scientific hypothesis. FOXO1
89 19757185 10.1007/s11033-009-9748-3 2010 Role of dephosphorylation of FOXO1 on apoptosis induced by wortmannin for non-Hodgkin's lymphoma cells. FOXO1
90 20709952 10.4049/jimmunol.1001430 2010 The MAPK/ERK and PI3K pathways additively coordinate the transcription of recombination-activating genes in B lineage cells. FOXO1
91 19198627 10.1038/onc.2008.502 2009 Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells. FOXO1
92 17254960 10.1016/j.cell.2007.01.009 2007 FoxOs in tumor suppression and stem cell maintenance. FOXO1
93 17254969 10.1016/j.cell.2006.12.029 2007 FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. FOXO1
94 17974917 10.1101/gad.453107 2007 FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf. FOXO1
95 16943287 10.1128/JVI.00983-06 2006 Epstein-Barr virus represses the FoxO1 transcription factor through latent membrane protein 1 and latent membrane protein 2A. FOXO1
96 15668399 10.1073/pnas.0406789102 2005 Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. FOXO1
97 15837766 10.1158/1078-0432.CCR-04-1857 2005 Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells. FOXO1
98 14747556 10.1128/jvi.78.4.1918-1927.2004 2004 The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway. FOXO1
99 12930690 NA 2003 [Detection of PAX3/PAX7-FKHR fusion transcript in rhabdomyosarcoma by one-step RT-PCR]. FOXO1
100 9823299 NA 1998 Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. FOXO1